Is nebulized cocaine a recommended first-line treatment for severe epistaxis (nosebleed)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

No, nebulized cocaine is not a recommended first-line treatment for severe epistaxis (nosebleed). The current first-line treatments for severe nosebleeds typically include applying direct pressure to the nose by pinching the nostrils for 10-15 minutes, using topical vasoconstrictors such as oxymetazoline (Afrin) nasal spray, applying ice packs to the bridge of the nose, and maintaining an upright sitting position with the head tilted slightly forward. For persistent bleeding, medical professionals may use nasal packing, chemical or electrical cauterization, or topical tranexamic acid.

Key Points to Consider

  • Cocaine, while it does have vasoconstrictive and anesthetic properties, carries significant risks including cardiovascular complications, potential for abuse, and legal restrictions 1.
  • Additionally, safer alternatives with similar therapeutic effects are readily available. Medical-grade topical vasoconstrictors combined with local anesthetics (like lidocaine with epinephrine) provide similar benefits without cocaine's risks and are therefore preferred in clinical practice for managing severe epistaxis 1.
  • The use of topical vasoconstrictors such as oxymetazoline is supported by studies, which report that 65% to 75% of patients have resolution of nasal bleeding with oxymetazoline 1.
  • Nasal endoscopy may be indicated in certain cases, particularly if bleeding was unusually difficult to control or if clinical symptoms or signs exist alerting the clinician to additional bleeding sites or intranasal pathology 1.

Treatment Options

  • Applying direct pressure to the nose by pinching the nostrils for 10-15 minutes
  • Using topical vasoconstrictors such as oxymetazoline (Afrin) nasal spray
  • Applying ice packs to the bridge of the nose
  • Maintaining an upright sitting position with the head tilted slightly forward
  • Nasal packing, chemical or electrical cauterization, or topical tranexamic acid for persistent bleeding

Important Considerations

  • Safer alternatives to nebulized cocaine are available and preferred due to the risks associated with cocaine use.
  • Medical professionals should consider the individual patient's needs and medical history when selecting a treatment option.
  • Nasal endoscopy may be necessary in certain cases to localize the bleeding site and guide targeted therapy.

From the Research

Nebulized Cocaine for Severe Epistaxis

  • There is no direct evidence to support the use of nebulized cocaine as a first-line treatment for severe epistaxis.
  • Topical cocaine has been used to treat epistaxis due to its anesthetic and vasoconstrictive properties, but it can have unpredictable cardiovascular effects 2.
  • Other treatments, such as topical tranexamic acid, have shown efficacy in achieving hemostasis in epistaxis, with a systematic review and meta-analysis finding that patients treated with topical tranexamic acid were 3.5 times more likely to achieve bleeding cessation at the first assessment 3.
  • A comparative study found that topical tranexamic acid was more effective than topical oxymetazoline in achieving hemostasis in anterior epistaxis 4.
  • Outpatient management of epistaxis often involves compressive therapy, oxymetazoline nasal spray, and directive nasal cautery, with topical therapy and nasal packing used if other methods are unsuccessful 5.
  • A study comparing 4% and 6% topical cocaine solutions for reduction of epistaxis induced by nasotracheal intubation found that both concentrations had comparable effects, but 6% cocaine may increase hemodynamic responses 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Epistaxis: Outpatient Management.

American family physician, 2018

Research

Comparison of 4% and 6% topical cocaine solutions for reduction of epistaxis induced by nasotracheal intubation.

Acta anaesthesiologica Taiwanica : official journal of the Taiwan Society of Anesthesiologists, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.